TNFSF10 and colorectal cancer: The iron oxide NPs in the NanoTRAIL formulation initiated oxidative stress, followed by reactive oxygen species (ROS)-triggered c-Jun N-terminal kinase (JNK) activation and subsequent autophagy-assisted DR5 upregulation, resulting in a significantly improved survival outcome in a colorectal cancer patient-derived xenograft model compared with TRAIL monotherapy.